This article has been updated from an earlier version to include stock quotes and details on the divestiture.

NEW YORK, Oct. 27 (GenomeWeb News) - Shares in Ciphergen lost some of the ground ground they gained early this afternoon on news that the company sold its BioSepra Process Division to Pall


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.